{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:11:50Z","timestamp":1793725910724,"version":"4.6.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T00:00:00Z","timestamp":1656374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T00:00:00Z","timestamp":1656374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Dupilumab, an anti-IL-4\u03b1 receptor antibody, is a new treatment for severe or refractory asthma. However, real-world evidence on the efficacy of dupilumab in patients with mild to moderate bronchial asthma is lacking.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We retrospectively evaluated the effects of dupilumab in 62 patients who received dupilumab for eosinophilic sinusitis comorbid with asthma at a single centre in Japan. Type 2 inflammatory markers, ACT, respiratory function tests, and forced oscillation technique (FOT) were analysed before, three months after, and one year after dupilumab administration, mainly in patients with mild to moderate asthma.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>FEV1, %FEV1, %FVC, treatment steps for asthma and ACT improved significantly after three months of dupilumab treatment. FeNO was markedly decreased, whereas IgE and eosinophil counts showed no significant changes. Pre- and post-treatment respiratory resistance (Rrs) and respiratory reactance (Xrs) correlated significantly with FEV1. Improvement in %FEV1 was associated with higher FeNO and higher serum IgE before dupilumab treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Dupilumab treatment for sinusitis may improve respiratory functions, asthma symptoms, and asthma treatment reduction, even if the associated bronchial asthma is not severe.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12890-022-02046-3","type":"journal-article","created":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T13:03:56Z","timestamp":1656421436000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Real-life effectiveness of dupilumab in patients with mild to moderate bronchial asthma comorbid with CRSwNP"],"prefix":"10.1186","volume":"22","author":[{"given":"Shunsuke","family":"Minagawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Araya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoaki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromichi","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Numata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyoshi","family":"Kuwano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Matsuwaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,28]]},"reference":[{"key":"2046_CR1","doi-asserted-by":"crossref","unstructured":"Numata T, Miyagawa H, Nishioka S, Okuda K, Utsumi H, Hashimoto M, et al. Efficacy of benralizumab for patients with severe eosinophilic asthma: A retrospective, real-life study. BMC Pulm Med. 2020;20(1).","DOI":"10.1186\/s12890-020-01248-x"},{"key":"2046_CR2","doi-asserted-by":"publisher","first-page":"609","DOI":"10.2147\/JAA.S311975","volume":"14","author":"T Numata","year":"2021","unstructured":"Numata T, Araya J, Miyagawa H, Okuda K, Fujita Y, Utsumi H, et al. Effectiveness of switching biologics for severe asthma patients in Japan: a single-center retrospective study. J Asthma Allergy. 2021;14:609\u201318.","journal-title":"J Asthma Allergy"},{"issue":"4","key":"2046_CR3","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.resinv.2021.03.003","volume":"59","author":"N Harada","year":"2021","unstructured":"Harada N, Ito J, Takahashi K. Clinical effects and immune modulation of biologics in asthma. Respir Investig. 2021;59(4):389\u201396. https:\/\/doi.org\/10.1016\/j.resinv.2021.03.003.","journal-title":"Respir Investig"},{"key":"2046_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2018.12.007","author":"F Napoletano","year":"2018","unstructured":"Napoletano F, Baron O, Vandenabeele P, Mollereau B, Fanto M. Intersections between regulated cell death and autophagy. Trends Cell Biol. 2018. https:\/\/doi.org\/10.1016\/j.tcb.2018.12.007.","journal-title":"Trends Cell Biol"},{"key":"2046_CR5","doi-asserted-by":"crossref","unstructured":"Dragonieri S, Carpagnano GE. Biological therapy for severe asthma. Asthma Res Pract. 2021;7(1).","DOI":"10.1186\/s40733-021-00078-w"},{"issue":"10221","key":"2046_CR6","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S0140-6736(19)33005-3","volume":"395","author":"MC Peters","year":"2020","unstructured":"Peters MC, Wenzel SE. Intersection of biology and therapeutics: type 2 targeted therapeutics for adult asthma. Lancet. 2020;395(10221):371\u201383. https:\/\/doi.org\/10.1016\/S0140-6736(19)33005-3.","journal-title":"Lancet"},{"issue":"10039","key":"2046_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(16)30307-5","volume":"388","author":"S Wenzel","year":"2016","unstructured":"Wenzel S, Castro M, Corren J, Maspero J, Wang L, Zhang B, et al. Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting \u03b22 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial. Lancet. 2016;388(10039):31\u201344. https:\/\/doi.org\/10.1016\/S0140-6736(16)30307-5.","journal-title":"Lancet"},{"issue":"26","key":"2046_CR8","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","volume":"378","author":"M Castro","year":"2018","unstructured":"Castro M, Corren J, Pavord ID, Maspero J, Wenzel S, Rabe KF, et al. Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma. N Engl J Med. 2018;378(26):2486\u201396.","journal-title":"N Engl J Med"},{"issue":"26","key":"2046_CR9","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1056\/NEJMoa1804093","volume":"378","author":"KF Rabe","year":"2018","unstructured":"Rabe KF, Nair P, Brusselle G, Maspero JF, Castro M, Sher L, et al. Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma. N Engl J Med. 2018;378(26):2475\u201385.","journal-title":"N Engl J Med"},{"issue":"2","key":"2046_CR10","first-page":"27","volume":"7","author":"A Kanda","year":"2019","unstructured":"Kanda A, Kobayashi Y, Asako M, Tomoda K, Kawauchi H, Iwai H. Regulation of interaction between the upper and lower airways in united airway disease. Med Sci. 2019;7(2):27.","journal-title":"Med Sci"},{"issue":"4","key":"2046_CR11","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1165\/rcmb.2009-0425OC","volume":"44","author":"G Hens","year":"2011","unstructured":"Hens G, Raap U, Vanoirbeek J, Meyts I, Callebaut I, Verbinnen B, et al. Selective nasal allergen provocation induces substance P-mediated bronchial hyperresponsiveness. Am J Respir Cell Mol Biol. 2011;44(4):517\u201323.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"2046_CR12","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1067\/mai.2001.113046","volume":"107","author":"GJ Braunstahl","year":"2001","unstructured":"Braunstahl GJ, Overbeek SE, KleinJan A, Prins JB, Hoogsteden HC, Fokkens WJ. Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways. J Allergy Clin Immunol. 2001;107(3):469\u201376.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"2046_CR13","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jaci.2003.10.068","volume":"113","author":"N Higashi","year":"2004","unstructured":"Higashi N, Taniguchi M, Mita H, Kawagishi Y, Ishii T, Higashi A, et al. Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): Involvement of chronic hyperplastic rhinosinusitis with nasal polyposis. J Allergy Clin Immunol. 2004;113(2):277\u201383.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"2046_CR14","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/alr.22064","volume":"8","author":"C John Staniorski","year":"2018","unstructured":"John Staniorski C, Price CPE, Weibman AR, Welch KC, Conley DB, Shintani-Smith S, et al. Asthma onset pattern and patient outcomes in a chronic rhinosinusitis population. Int Forum Allergy Rhinol. 2018;8(4):495\u2013503.","journal-title":"Int Forum Allergy Rhinol"},{"issue":"5","key":"2046_CR15","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.anai.2021.01.012","volume":"126","author":"TM Laidlaw","year":"2021","unstructured":"Laidlaw TM, Bachert C, Amin N, Desrosiers M, Hellings PW, Mullol J, et al. Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma. Ann Allergy, Asthma Immunol. 2021;126(5):584\u201392. https:\/\/doi.org\/10.1016\/j.anai.2021.01.012.","journal-title":"Ann Allergy, Asthma Immunol."},{"issue":"10209","key":"2046_CR16","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","volume":"394","author":"C Bachert","year":"2019","unstructured":"Bachert C, Han JK, Desrosiers M, Hellings PW, Amin N, Lee SE, et al. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet. 2019;394(10209):1638\u201350. https:\/\/doi.org\/10.1016\/S0140-6736(19)31881-1.","journal-title":"Lancet."},{"key":"2046_CR17","unstructured":"Youssef AM, Abdel-Naby Awad OG, Taha M. Pulmonary function of patients with chronic rhinosinusitis and the impact of endoscopic sinus surgery. http:\/\/oto-open.org"},{"issue":"12","key":"2046_CR18","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1016\/j.rmed.2006.03.009","volume":"100","author":"JV Cavalcanti","year":"2006","unstructured":"Cavalcanti JV, Lopes AJ, Jansen JM, Melo PL. Detection of changes in respiratory mechanics due to increasing degrees of airway obstruction in asthma by the forced oscillation technique. Respir Med. 2006;100(12):2207\u201319.","journal-title":"Respir Med"},{"key":"2046_CR19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1475-925X-10-65","volume":"10","author":"J Ohishi","year":"2011","unstructured":"Ohishi J, Kurosawa H. Time lag between oscillatory pressure and flow affecting accuracy of forced oscillation technique. Biomed Eng Online. 2011;10:2\u20135.","journal-title":"Biomed Eng Online"},{"issue":"2","key":"2046_CR20","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.alit.2016.12.005","volume":"66","author":"M Ichinose","year":"2017","unstructured":"Ichinose M, Sugiura H, Nagase H, Yamaguchi M, Inoue H, Sagara H, et al. Japanese guidelines for adult asthma 2017. Allergol Int. 2017;66(2):163\u201389.","journal-title":"Allergol Int"},{"key":"2046_CR21","unstructured":"Global initiative for asthma: Asthma management and prevention, 2019. 2019;49(5)."},{"key":"2046_CR22","unstructured":"GINA. Global strategy for asthma management and prevention (2021 update). 2021;"},{"issue":"4","key":"2046_CR23","first-page":"183","volume":"31","author":"VJMI Lund","year":"1993","unstructured":"Lund VJMI. Staging in rhinosinusitus. Rhinology. 1993;31(4):183\u20134.","journal-title":"Rhinology"},{"issue":"1","key":"2046_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2169\/internalmedicine.49.2191","volume":"49","author":"S Kanda","year":"2010","unstructured":"Kanda S, Fujimoto K, Komatsu Y, Yasuo M, Hanaoka M, Kubo K. Evaluation of respiratory impedance in asthma and COPD by an impulse oscillation system. Intern Med. 2010;49(1):23\u201330.","journal-title":"Intern Med"},{"issue":"2","key":"2046_CR25","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jaip.2019.08.050","volume":"8","author":"J Corren","year":"2020","unstructured":"Corren J, Castro M, O\u2019Riordan T, Hanania NA, Pavord ID, Quirce S, et al. Dupilumab efficacy in patients with uncontrolled, moderate-to-severe allergic asthma. J Allergy Clin Immunol Pract. 2020;8(2):516\u201326. https:\/\/doi.org\/10.1016\/j.jaip.2019.08.050.","journal-title":"J Allergy Clin Immunol Pract."},{"issue":"6","key":"2046_CR26","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1080\/02770903.2020.1729380","volume":"58","author":"K Hamada","year":"2021","unstructured":"Hamada K, Oishi K, Chikumoto A, Murakawa K, Ohteru Y, Matsuda K, et al. Impact of sinus surgery on type 2 airway and systemic inflammation in asthma. J Asthma. 2021;58(6):750\u20138. https:\/\/doi.org\/10.1080\/02770903.2020.1729380.","journal-title":"J Asthma."},{"issue":"3","key":"2046_CR27","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/lary.27008","volume":"128","author":"ZM Soler","year":"2018","unstructured":"Soler ZM, Jones R, Le P, Rudmik L, Mattos JL, Nguyen SA, et al. Sino-Nasal outcome test-22 outcomes after sinus surgery: a systematic review and meta-analysis. Laryngoscope. 2018;128(3):581\u201392.","journal-title":"Laryngoscope"},{"issue":"2","key":"2046_CR28","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.jaip.2019.07.016","volume":"8","author":"JF Maspero","year":"2020","unstructured":"Maspero JF, Katelaris CH, Busse WW, Castro M, Corren J, Chipps BE, et al. Dupilumab efficacy in uncontrolled, moderate-to-severe asthma with self-reported chronic rhinosinusitis. J Allergy Clin Immunol Pract. 2020;8(2):527\u201339. https:\/\/doi.org\/10.1016\/j.jaip.2019.07.016.","journal-title":"J Allergy Clin Immunol Pract."},{"issue":"9","key":"2046_CR29","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1152\/japplphysiol.00093.2013","volume":"115","author":"VJ Kelly","year":"2013","unstructured":"Kelly VJ, Sands SA, Harris RS, Venegas JG, Brown NJ, Stuart-Andrews CR, et al. Respiratory system reactance is an independent determinant of asthma control. J Appl Physiol. 2013;115(9):1360\u20139.","journal-title":"J Appl Physiol"},{"issue":"2","key":"2046_CR30","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/all.13938","volume":"75","author":"L Antonicelli","year":"2020","unstructured":"Antonicelli L, Tontini C, Marchionni A, Lucchetti B, Garritani MS, Bil\u00f2 MB. Forced oscillation technique as method to document and monitor the efficacy of mepolizumab in treating severe eosinophilic asthma. Allergy Eur J Allergy Clin Immunol. 2020;75(2):433\u20136.","journal-title":"Allergy Eur J Allergy Clin Immunol"},{"issue":"1","key":"2046_CR31","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/crj.13268","volume":"15","author":"N Higaki","year":"2021","unstructured":"Higaki N, Iwamoto H, Yamaguchi K, Sakamoto S, Horimasu Y, Masuda T, et al. Correlations of forced oscillometric bronchodilator response with airway inflammation and disease duration in asthma. Clin Respir J. 2021;15(1):48\u201355.","journal-title":"Clin Respir J"},{"issue":"1","key":"2046_CR32","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000452479","volume":"93","author":"E Crisafulli","year":"2016","unstructured":"Crisafulli E, Pisi R, Aiello M, Vigna M, Tzani P, Torres A, et al. Prevalence of small-airway dysfunction among COPD patients with different GOLD stages and its role in the impact of disease. Respiration. 2016;93(1):32\u201341.","journal-title":"Respiration"},{"key":"2046_CR33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.rmed.2016.05.006","volume":"116","author":"OS Usmani","year":"2016","unstructured":"Usmani OS, Singh D, Spinola M, Bizzi A, Barnes PJ. The prevalence of small airways disease in adult asthma: a systematic literature review. Respir Med. 2016;116:19\u201327. https:\/\/doi.org\/10.1016\/j.rmed.2016.05.006.","journal-title":"Respir Med"},{"issue":"1","key":"2046_CR34","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jaip.2019.06.035","volume":"8","author":"YH Hsiao","year":"2020","unstructured":"Hsiao YH, Su KC, Lee YC, Ko HK, Perng DW. Small airway dysfunction by impulse oscillometry in symptomatic patients with preserved pulmonary function. J Allergy Clin Immunol Pract. 2020;8(1):229-235.e3.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2046_CR35","unstructured":"Wechsler ME, Ford LB, Maspero JF, Pavord ID, Papi A, Bourdin A, et al. Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study. Lancet Respir Med. 2021; https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2213260021003222"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-022-02046-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-022-02046-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-022-02046-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T13:04:03Z","timestamp":1656421443000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-022-02046-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,28]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2046"],"URL":"https:\/\/doi.org\/10.1186\/s12890-022-02046-3","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,28]]},"assertion":[{"value":"16 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For this retrospective study, written informed consent from the participants was unavailable and unnecessary. The Ethical Committee of Jikei University School of Medicine stated that patient consent was not necessary for this retrospective study. We performed opt-out consent on the website of the Matsuwaki clinic. This study was approved by the Ethical Committee of Jikei University School of Medicine [\u2013]. The director\/administer of Jikei University Hospital granted us permission to access the medical records. The data used in this study was anonymized before its use. The study was conducted in accordance with the declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there are no financial or non-financial types of interest related to the submitted article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"258"}}